Repurposed Skin Cancer Drug Effective for Rare Brain Cancer

A multi-institutional study has identified a new treatment option for papillary craniopharyngioma, a rare form of cancer that forms along the central nervous system. “Brain tumors are rare, and papillary craniopharyngioma tumors are rare among this group,” said Adam Cohen, M.D., co-director of the neuro-oncology program at the Inova Schar Cancer Institute. “We found that…

Read More

How Testicular Cancer Affects Sexual Health

Inger Rosner, MD, is a board-certified urologic oncologist at Inova Scar Cancer Institute’s Genitourinary Cancer Program. Dr. Rosner has published dozens of papers based on her research in the field of urologic oncology. She answers common questions about testicular cancer and sexual health, and provides hope for those with this diagnosis. Finding out you have…

Read More

Tigerlily Foundation Partners with Inova Life with Cancer on #InclusionPledge to Eliminate Disparities for Black Women Living with Breast Cancer

inova logo

Fairfax, VA – Tigerlily Foundation announced today that Inova Life with Cancer has joined the #InclusionPledge – an unprecedented initiative focused on diversity, inclusion, and eliminating disparities for Black women living with breast cancer.  As an organization dedicated to ending disparities in our lifetime, Tigerlily Foundation recognizes that recent world events highlight the systemic racism that…

Read More

Know the Facts About Head and Neck Cancer

April is Head and Neck Cancer Awareness Month  — an important time to talk about this lesser-known cancer type. Though cases are increasing in the U.S., many people don’t know the signs of head and neck cancer — or what treatment they may need. Inova head and neck cancer experts John Deeken, MD, and Gopal…

Read More

Suzuki Receives 2023 AstraZeneca Lung Cancer Research Award

The Board of Directors of The Thoracic Surgery Foundation has named Kei Suzuki, MD, the recipient of the 2023 AstraZeneca Lung Cancer Research Award. Suzuki was recognized for his project, “Single-cell RNA sequence profiling of tumor-immune microenvironment for precision therapy in resectable lung cancer.”  “This funding is crucial to take the research to the next…

Read More

Some Patients Fear Lung Cancer Screenings. Here’s Why They Shouldn’t.

Priya Patel, MD is an interventional pulmonologist who is board certified in interventional pulmonology, pulmonary disease, critical care and internal medicine at Inova Schar Cancer Institute. She has a special interest in the management of complex airways and pleural diseases, lung cancer, procedural education and procedure related quality improvement initiatives. Working as part of a…

Read More

Breast Cancer Screening and Detection: 5 Frequently Asked Questions

Kathleen Harden, MD is a breast oncology physician, board-certified in medical oncology and internal medicine at Inova Schar Cancer Institute. She has a special interest and conducts research in the management of breast cancer. Her research is focused on early phase clinical trials in breast cancer, breast cancer genomics and individualized treatment for patients based…

Read More